Trial intelligence / Profile preview

Prophylactic ondansetron to prevent hypotension after spinal anesthesia in preeclampsia

ChiCTR2400080284Phase 4Not yet recruiting

Sponsor
Jiaxing Maternity and Child Health Care Hospital
Start
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ondansetron in preeclampsia (2 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoint: Incidence of hypotension after spinal anesthesia. Planned start Jan 2024; status: not yet recruiting.

02

Drugs

ondansetron
03

Conditions

preeclampsia

Beyond the preview

Go deeper on ChiCTR2400080284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400080284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call